Switch to:
More From Other Websites
Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals Apr 01 2015
Salix had a $13B offer on the table before accounting problems crashed share price Mar 24 2015
Talking Allergan at Tulane: a 'Horse Choker,' the 'Shamarendum' and More Mar 24 2015
ALLERGAN INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of... Mar 18 2015
Sale of Allergan to Actavis is finalized; CEO David Pyott stepping down Mar 17 2015
Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog Mar 17 2015
Cramer: Market cross currents Mar 17 2015
Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog Mar 17 2015
Allergan sale complete, CEO Pyott steps down Mar 17 2015
American Airlines Group (AAL) to Enter Coveted S&P 500 - Analyst Blog Mar 17 2015
Allergan sale to Actavis complete; CEO David Pyott is leaving Mar 17 2015
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook Mar 17 2015
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews Mar 17 2015
Actavis Completes Acquisition of Allergan Mar 17 2015
American Airlines Joining The S&P 500, Analysts Bullish On U.S. Skies Mar 17 2015
Cramer's Stop Trading: ESPR Mar 17 2015
Actavis says Allergan's Pyott won't join new company's board Mar 17 2015
American Airlines Replaces Allergan in S&P 500 Mar 17 2015
Actavis Completes Allergan Acquisition Mar 17 2015
Cramer's Mad Dash: ACT & MGM Mar 17 2015
Actavis Completes Allergan Acquisition Mar 17 2015
Actavis Completes Allergan Acquisition Mar 17 2015
Actavis Completes Allergan Acquisition Mar 17 2015
European Commission Clears Actavis' Pending Acquisition of Allergan Mar 16 2015
European Commission Clears Actavis' Pending Acquisition of Allergan Mar 16 2015
Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of... Mar 12 2015
Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of... Mar 10 2015
Actavis and Allergan Shareholders Approve Proposals Related to Actavis’ Planned Acquisition of... Mar 10 2015
Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred... Mar 03 2015
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of... Mar 02 2015
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of... Mar 02 2015
FDA Approves Allergan's NATRELLE INSPIRA™ Round Gel-Filled Breast Implants Feb 27 2015
Actavis Announces Proposed Public Offerings of Ordinary Shares and Mandatory Convertible Preferred... Feb 20 2015
Actavis Announces Intention to Adopt "Allergan" Corporate Name Feb 19 2015
MEDIA-Tax inversion rules could lead U.S. drugmakers selling to overseas buyers : Ackman - Bloomberg Feb 12 2015
Allergan tops Street 4Q forecasts Feb 04 2015
Allergan Reports Fourth Quarter 2014 Operating Results Feb 04 2015
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC Jan 26 2015
Asanko Gold Announces C$40 Million Bought Deal Financing Jan 20 2015
Asanko Gold Mine Construction Update Jan 15 2015
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis'... Jan 12 2015
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan... Dec 23 2014
Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock Dec 09 2014
Ackman's Pershing Square sees big payoff from Allergan deal Nov 26 2014
Actavis mulls job cuts, China expansion - Bloomberg Nov 24 2014
Valeant slashes stake in Allergan after losing bid Nov 21 2014
Ackman supports Allergan's $66 billion sale to Actavis Nov 18 2014
US STOCKS-S&P 500 hits record again; Actavis rallies Nov 18 2014
Actavis to spend $66 billion on Allergan Nov 17 2014
Allergan agrees to $66 billion Actavis offer; Valeant walks Nov 17 2014
Actavis to buy Botox-maker Allergan for $66 billion Nov 17 2014
Losing Allergan deals blow to Valeant reputation Nov 17 2014
Ackman makes $2.2bn despite Allergan bid failure Nov 17 2014
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion... Nov 17 2014
Actavis to buy US Botox-maker Allergan for $66 billion Nov 17 2014
Valeant Comments On Allergan Announcement Nov 17 2014
Allergan near buyout of up to $65 billion to escape Valeant, Ackman - source Nov 16 2014
Botox-maker Allergan nears deal with Actavis Nov 16 2014
Allergan near buyout of up to $65 billion to escape Valeant, Ackman - source Nov 16 2014
Jana in third quarter took new stake in Valeant, upped stake in eBay Nov 14 2014
Actavis may buy Allergan for at least $60 billion - Bloomberg Nov 12 2014
Allergan amends shareholder meeting bylaws ahead of December 18 meet Nov 12 2014
Allergan deal inches forward with court's decision Nov 04 2014
U.S. court sets up Ackman, Valeant to vote at Allergan meeting Nov 04 2014
Allergan says has been approached by another party about a deal Nov 03 2014
Valeant, Allergan trade barbs as higher bid floated Oct 27 2014
Valeant says ready to raise Allergan bid to at least $200/share Oct 27 2014
Valeant: We'll bump Allergan offer to $200 a share Oct 27 2014
Allergan tops Street 3Q forecasts Oct 27 2014
Top Allergan holder Paulson urges deal with Shire -sources Oct 20 2014
Valeant says may raise Allergan bid; beats on profit Oct 20 2014
EXCLUSIVE-Allergan shareholder Paulson & Co urges deal with Shire- sources Oct 20 2014
Exclusive - Actavis plans new merger approach for Allergan - sources Oct 07 2014
Allergan CEO resigns from Edwards Lifesciences' board Oct 03 2014
Allergan ordered to show 'business strategy' docs: Frankel Sep 23 2014
COLUMN-Allergan ordered to show 'business strategy' docs: Frankel Sep 22 2014
Allergan approaches Salix to fight Valeant bid Aug 19 2014
Valeant extends takeover bid for Botox maker Allergan Aug 15 2014
US STOCKS-Futures point to flat open, Ukraine still in focus Aug 12 2014
UPDATE 2-Drug-maker Valeant begins exchange offer for Allergan Jun 19 2014
Drug-maker Valeant begins exchange offer for Allergan Jun 18 2014
Valeant launches hostile bid for Allergan Jun 18 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK